Handelsavisen
prelaunch
Companies Financials 088350.KS
08
088350.KS KRX Life & Health Insurance

Hanwha Life Insurance Co Ltd

$4 310,00
Open in Charts → Attach watcher ⌖
USD
Set alert
LatestSouth Korean auto insurance loss rates climb as traffic volume surges
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
0,00 %
Op margin
ROE
4,6 %
Net margin
Debt / equity
1,56
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Hanwha Life Insurance Co Ltd provides life and health insurance products in South Korea and operates primarily through its insurance underwriting and investment management activities.

Business. Hanwha Life Insurance Co Ltd (088350.KS) is a South Korean life and health insurance company headquartered in Seoul. The firm operates within the Financials sector, specifically focusing on the Life & Health Insurance industry. It is primarily listed on the Korea Exchange (KRX). Specific details regarding operating segments or geographic revenue breakdowns are not provided.

Classification92 %
SectorFinancials
Business sectorInsurance
IndustryLife & Health Insurance
Generated · model-assisted
Sell-side consensus
HOLD12 analysts
4 buy5 hold3 sell
Avg 12m price target4 700,00

Analyst recommendations

12 analysts · consensus Hold
Buy4
Hold5
Sell3
12-month price target
4 700,00
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Hold
12 analysts · indicative
Ownership
not yet wired
Profitability
4,6 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

1
  • MARKETSSouth Korean auto insurance loss rates climb as traffic volume surges2026-06-23
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials · THIS SECTOR−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 088350.KS. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    Briefing · model-assisted

    Hanwha Life Insurance Co Ltd (088350.KS) is currently undergoing its first analysis, meaning there is no prior basis for computing material changes or deltas in its financial profile. Consequently, no specific operational shifts, earnings surprises, or strategic pivots can be identified from recent data to drive a narrative of change. The company’s current market footprint is characterized by limited analyst coverage, with only three analysts tracking the stock. There are no reported index memberships, and data on top holders and officer counts are currently unavailable or recorded as zero, suggesting a lack of transparent institutional ownership or executive disclosure in the current dataset. Market attention appears minimal, as cross-source signals indicate zero dispatches per day over the 30-day period leading up to July 17, 2026. This absence of news flow or sentiment data further underscores the lack of recent catalysts or public discourse surrounding the insurer during this window. Given the absence of material changes, watcher signals, or recent news activity, the significance of Hanwha Life Insurance’s current status lies in its baseline establishment. Investors and analysts are starting from a clean slate, with foundational data points available through financials, estimates, and ESG reports, but no immediate trends or events to interpret.

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Hanwha Life Insurance Co Ltd (088350.KS) is a South Korean life and health insurance company headquartered in Seoul. The firm operates within the Financials sector, specifically focusing on the Life & Health Insurance industry. It is primarily listed on the Korea Exchange (KRX). Specific details regarding operating segments or geographic revenue breakdowns are not provided.

    Classification92 %
    SectorFinancials
    Business sectorInsurance
    IndustryLife & Health Insurance
    AI synthesis
    GENERATED

    Hanwha Life Insurance Co Ltd maintains a capital structure with a debt-to-equity ratio of 1.56, indicating a moderate reliance on debt financing. The company's liquidity position is characterized as medium, with free cash flow of 733.88 billion KRW and cash and equivalents of 2.98 trillion KRW. However, its net cash position is negative after subtracting total debt, signaling potential liquidity constraints.

    Profitability metrics show a return on equity (ROE) of 4.62%, which is a key performance indicator for insurance firms. This ROE is below the typical industry benchmark for life insurers, which often exceed 10% in stable markets. The return on assets (ROA) of 0.36% is also weak, suggesting that the company is not efficiently utilizing its asset base to generate returns.

    The company's revenue is concentrated in its domestic South Korean market, with no disclosed international operations. This geographic concentration exposes the company to local economic and regulatory risks, including interest rate fluctuations and demographic trends affecting insurance demand.

    Looking ahead, Hanwha Life Insurance Co Ltd is projected to experience modest growth, with analysts providing a mean price target of 4,700 KRW and a median of 4,900 KRW. The company's operating income of 215.39 billion KRW and net income of 64.13 billion KRW suggest a stable but not rapidly growing business model.

    Risk factors include a medium liquidity risk and a low dilution risk. The company's capital expenditure of -303.89 billion KRW indicates a reduction in capital spending, which may reflect a strategic shift or cost-cutting measures. No significant dilution sources are identified in the latest filings, and the dilution potential is assessed as low.

    Recent events include the publication of the latest financial data, which provides a snapshot of the company's performance. No major regulatory or operational events were disclosed in the most recent filings, and the company's risk assessment remains stable.

    Hanwha Life Insurance Co Ltd (088350.KS) is currently undergoing its first analysis, meaning there is no prior basis for computing material changes or deltas in its financial profile. Consequently, no specific operational shifts, earnings surprises, or strategic pivots can be identified from recent data to drive a narrative of change. The company’s current market footprint is characterized by limited analyst coverage, with only three analysts tracking the stock. There are no reported index memberships, and data on top holders and officer counts are currently unavailable or recorded as zero, suggesting a lack of transparent institutional ownership or executive disclosure in the current dataset. Market attention appears minimal, as cross-source signals indicate zero dispatches per day over the 30-day period leading up to July 17, 2026. This absence of news flow or sentiment data further underscores the lack of recent catalysts or public discourse surrounding the insurer during this window. Given the absence of material changes, watcher signals, or recent news activity, the significance of Hanwha Life Insurance’s current status lies in its baseline establishment. Investors and analysts are starting from a clean slate, with foundational data points available through financials, estimates, and ESG reports, but no immediate trends or events to interpret.

    Key takeaways
    • Hanwha Life Insurance Co Ltd has a debt-to-equity ratio of 1.56, indicating a moderate reliance on debt financing.
    • The company's ROE of 4.62% is below the typical industry benchmark for life insurers.
    • Revenue is concentrated in the South Korean market, exposing the company to local economic and regulatory risks.
    • Analysts project a mean price target of 4,700 KRW, suggesting modest growth expectations.
    • The company's liquidity risk is assessed as medium, with a negative net cash position after subtracting total debt.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $4 310,00
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $13.88T
    Net cash
    -$18.64T
    Current ratio
    Debt / equity
    1.6
    ROA
    0.4%
    ROE
    4.6%
    Cash conversion
    683.0%
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    696,23
    Predicted surprise
    0,00
    Beat probability
    45 %
    Analysts
    12
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-20 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate696,23
    Revenueno estimateno estimate766,9B KRW
    Operating incomeno estimateno estimate745,7B KRW
    Full-year consensus mean (period as reported by source) · consensus in KRW. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution12 analysts
    Strong buy1
    Buy3
    Hold5
    Sell3
    Strong sell0
    12-month price target$4 700,00 · Median $4 900,00
    Low $2 600,00High $6 300,00
    Operating income · consensus745,7B KRW
    EPS surprise
    −0,5 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$2 600,00
    Mean$4 700,00
    Median$4 900,00
    High$6 300,00
    Spot$4 310,00
    +9.0 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    ROE4,6 %Below median
    D/E1,56Bottom quartile
    Cash Conv6,83Above P75

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    • Return On Assets
      net_income / total_assets
    Source documents
    • Hanwha Life Insurance Co Ltd Market data — financials · 2026-05-26
    • Hanwha Life Insurance Co Ltd Market data — analyst estimates · 2026-05-26
    • Hanwha Life Insurance Co Ltd Market data — ESG · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    088350.KSCanonical
    KRX · USD

    Intel & risk

    PredictorBeat prob45 %Surprise0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage